Almotriptan

CHEMBL1505 Phase 4 Onaylandı Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
335.5 g/mol
LogP
1.6
Phase
4

A triptan medication that relieves migraine headaches by binding to serotonin receptors in the brain, causing constriction of dilated blood vessels around the brain and blocking the release of pain-causing substances from nerve endings. It is taken at the onset of a migraine to reduce headache severity and associated symptoms like nausea and light sensitivity.

Moleküler Ağırlık

335,5000 g/mol

LogP

1,60

TPSA

64,80 Ų

Lipinski RO5

Geçer

Terapötik Alanlar

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CN(C)CCc1c[nH]c2ccc(CS(=O)(=O)N3CCCC3)cc12

InChI

InChI=1S/C17H25N3O2S/c1-19(2)10-7-15-12-18-17-6-5-14(11-16(15)17)13-23(21,22)20-8-3-4-9-20/h5-6,11-12,18H,3-4,7-10,13H2,1-2H3

Molecular Formula

C17H25N3O2S

HBD / HBA

1 / 4

Döndürülebilir Bağlar

6

Ağır Atomlar

23

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

A triptan medication that relieves migraine headaches by binding to serotonin receptors in the brain, causing constriction of dilated blood vessels around the brain and blocking the release of pain-causing substances from nerve endings. It is taken at the onset of a migraine to reduce headache severity and associated symptoms like nausea and light sensitivity.

Yes, Almotriptan is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1505. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 123606. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.